Royalty Pharma PLC (RPRX) Stock Holdings & Institutional Ownership

Royalty Pharma PLC

RPRX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Patient Capital Management	Equity	3,643,716	$174,789,053	6.52%	+9.30%
Dorsey Asset Management	Equity	2,276,570	$109,207,063	8.70%	+0.76%
Farallon Capital Management	Equity	493,000	$23,649,210	0.14%	+100%

Total Shares Held: 6,413,286

Total Value Reported: $307,645,326

Average Allocation per Portfolio 5.12%

Largest Single Portfolio Allocation: 8.70%

Largest Shareholder: Patient Capital Management

Change in Total Shares Held (Q on Q): +820,142

Percentage Change in Shares Held (Q on Q): 14.66%

Number of Current Holders: 3

Number of New Holders (Q on Q): 1

Number of Funds with Additions (Q on Q): 3

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 0